← Back to headlines
Plasma Key in Therapies for Rare Diseases, Grifols Boosts Research
Grifols is collaborating with patient associations to advance research into plasma-based therapies, which are crucial for patients with rare diseases, aiming to accelerate early diagnosis.
28 Feb, 04:50 — 28 Feb, 04:50
ℹOnly 1 source covers this story
